Slingsby Brian Taylor
Insider CIK 1963901 · MLYS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MLYS Mineralys Therapeutics, In | S Sale | 2026-09-22 | 2026-09-24 | 104,320 | $28.81 | $3.01M | 7,805,718 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-09-22 | 2026-09-24 | 104,320 | $28.81 | $3.01M | 7,805,718 | SEC↗ |
| MLYS Mineralys Therapeutics, In | J Other deriv | 2026-02-19 | 2026-02-20 | 8,300 | — | $0 | 8,300 | SEC↗ |
| MLYS Mineralys Therapeutics, In | J Other deriv | 2026-02-19 | 2026-02-20 | 8,300 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2026-02-19 | 2026-02-20 | 8,300 | — | $0 | 8,300 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2026-02-19 | 2026-02-20 | 6,200 | — | $0 | 6,200 | SEC↗ |
| MLYS Mineralys Therapeutics, In | J Other | 2026-02-19 | 2026-02-20 | 6,200 | — | $0 | 7,910,038 | SEC↗ |
| MLYS Mineralys Therapeutics, In | J Other | 2026-02-19 | 2026-02-20 | 6,200 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-20 | 2025-11-21 | 1,000,000 | $43.35 | $43.35M | 7,903,838 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2025-03-13 | 2025-04-25 | 259,259 | $13.50 | $3.50M | 8,903,838 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2025-02-13 | 2025-02-24 | 32,900 | — | $0 | 32,900 | SEC↗ |
| MLYS Mineralys Therapeutics, In | J Other deriv | 2025-02-13 | 2025-02-24 | 32,900 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | J Other deriv | 2025-02-13 | 2025-02-24 | 32,900 | — | $0 | 32,900 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-07-24 | 2024-07-26 | 550,000 | $13.05 | $7.18M | 8,644,579 | SEC↗ |
| MLYS Mineralys Therapeutics, In | J Other deriv | 2024-05-22 | 2025-01-07 | 22,000 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | J Other deriv | 2024-05-22 | 2025-01-07 | 22,000 | — | $0 | 22,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2024-05-22 | 2024-05-23 | 22,000 | — | $0 | 22,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | J Other deriv | 2023-07-12 | 2023-07-14 | 44,000 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | J Other deriv | 2023-07-12 | 2023-07-14 | 88,000 | — | $0 | 88,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion deriv | 2023-02-14 | 2023-02-16 | 2,142,751 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion deriv | 2023-02-14 | 2023-02-16 | 2,171,342 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion | 2023-02-14 | 2023-02-16 | 4,314,093 | — | $0 | 8,944,579 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2023-02-14 | 2023-02-16 | 250,000 | $16.00 | $4.00M | 9,194,579 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-02-09 | 2023-02-13 | 44,000 | — | $0 | 44,000 | SEC↗ |